Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Paracetamol,Codeine Phosphate
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Elite Pharma Launches Acetaminophen and Codeine Tablets for Mild Pain Management
Details : Acetaminophen & codeine phosphate is a pain relief medicine. It is approved for use in adults for relief of mild to moderate pain & the management of moderate to severe pain.
Product Name : Tylenol-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 10, 2024
Lead Product(s) : Paracetamol,Codeine Phosphate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Paracetamol,Caffeine,Codeine Phosphate
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : LaviPharm
Deal Size : Undisclosed
Deal Type : Acquisition
Asset Purchase Agreement for Lavipharm
Details : Company acquires two analgesic pharmaceutical products, Lonarid N® and Lonalgal®, used for fever and pain, for Greece and Cyprus markets with the intention to commercialize them internationally.
Product Name : Lonarid N
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 01, 2023
Lead Product(s) : Paracetamol,Caffeine,Codeine Phosphate
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : LaviPharm
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 08, 2015
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 06, 2014
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable